Compare Danaher Corporation (DHR) vs Omnicom Group Inc. (OMC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Danaher Corporation vs Omnicom Group Inc. — how do they compare? Danaher Corporation trades at $219.8 (market cap $152.87B), while Omnicom Group Inc. trades at $76.46 (market cap $20.97B). The key difference: Danaher Corporation is far larger — about 7.3× Omnicom Group Inc.'s market cap, and Omnicom Group Inc. pays the higher dividend (4.19%). Which is the better fit depends on your goals — on Pluang, investors hold Danaher Corporation for 69 Days and Omnicom Group Inc. for 63 Days on average.
| DHR | OMC | |
|---|---|---|
Market Cap | $152.87B | $20.97B |
Volume | 5,228,698 | 2,092,899 |
Sector | Health | Media |
52-Week High | $242.05 | $88.94 |
52-Week Low | $161.91 | $67.27 |
Typical Hold Time | 69 Days | 63 Days |
Enterprise Value | $175.08B | $29.05B |
Dividend Yield | 0.74% | 4.19% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $218.49, up 1.36% on the day, with a bullish technical signal and consistent earnings beats in recent quarters. The stock shows strong profitability with a 58.51% gross margin and 15.95% net income margin, though revenue growth has been modest. Analyst consensus is strongly bullish with a $230.31 price target, supported by institutional buying activity and a recent dividend announcement.
The outlook for DHR is positive, driven by earnings momentum and institutional confidence, but risks include elevated valuation multiples and competitive pressures in the healthcare sector. Investors should weigh the strong analyst support against potential margin compression and macroeconomic headwinds affecting capital spending.
Omnicom Group (OMC) trades at $76.48, up 2.15% with mixed technical signals showing bullish overall but bearish moving averages. The company reported strong revenue growth to $17.27B in 2025 but posted a net loss of -$54.50M due to higher taxes. Recent news highlights leadership in digital marketing and $3.3B in new H1 2026 billings, while analyst consensus remains cautious with 58.83% hold ratings.
OMC presents a value opportunity with attractive P/S of 0.86 and consensus price target of $100.50 offering 31% upside, though high P/E of 206.62 and recent earnings misses pose concerns. Key risks include advertising market volatility and debt levels, while AI capabilities and post-Interpublic synergies provide growth catalysts for patient investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →About Omnicom Group Inc.
Omnicom is the world's second- largest ad holding company, based on annual revenue. The firm's services, which include traditional and digital advertising and public relations, are provided worldwide, with over 85% of its revenue coming from more developed regions such as North America and Europe.
Read more on OMC →
